Various cancer investigations identified that FOXO3a transcription factor has a significant inhibition, and its interactions with diverse microRNAs affected cancer cell proliferation, apoptosis, and cell cycle progression, but this effect has an uncertainty in hepatocellular carcinoma. Here, FOXO3 is linked to hepatocellular carcinoma.